Ravi Maharjan | Pharmaceutics | Best Researcher Award

Published on by Academic Achievements

Dr. Ravi Maharjan | Pharmaceutics | Best Researcher Award

Dr. Ravi Maharjan | Pharmaceutics | Assistant Research Professor at Yonsei University | South Korea

Pharmaceutics is the foundation of Dr. Ravi Maharjan’s distinguished career as a research professor at Yonsei University, Korea, where he has been at the forefront of integrating AI/ML and Digital Twin technologies to revolutionize biopharmaceutical manufacturing, particularly in mRNA and siRNA-based lipid nanoparticle (LNP) vaccine development. Dr. Ravi Maharjan earned his PhD in Pharmaceutics and has since developed a deep expertise in biopharmaceutical process optimization, continuous manufacturing, lyophilization, stabilization strategies, and innovative delivery approaches targeting ocular and brain tissues. His professional experience spans extensive teaching, mentoring, and research leadership roles, where he has guided national and international collaborations with universities, pharmaceutical companies, and research institutions, including Pusan National University, CHA University, RCPE, RNAAnalytics Austria, and IMDEA Spain, demonstrating his ability to bridge academic research with industrial applications. Dr. Ravi Maharjan’s research interests focus on applying AI/ML algorithms for predictive modeling of complex pharmaceutical processes, optimizing formulations, ensuring protein stability, and enhancing the physical and biological stability of therapeutics. His work integrates pharmaceutics, process analytical technologies (PAT), quality by design (QbD), experimental design (DOE), and computational modeling to advance next-generation biopharmaceutical platforms. Among his key research skills are data-driven formulation design, predictive modeling, digital twin deployment, computational optimization of LNP delivery, lyophilized formulation screening, molecular simulation, process monitoring, and the translation of lab-scale research into continuous manufacturing systems. Dr. Ravi Maharjan has an impressive record of scholarly contributions, including over 23 SCIE Q1 publications, two books, two book chapters, more than 115 peer-review assignments, over 30 conference presentations, and eight invited talks. He has served as associate editor for Pharmaceutical Science and Technology (USA), editorial board member for Scientific Reports (Nature Portfolio, UK), Pharmaceutics (Switzerland), and Current Pharmaceutical Biotechnology (UAE), as well as conference organizer for multiple international events. His awards and honors recognize his contributions to both fundamental pharmaceutics and applied biopharmaceutical manufacturing, highlighting his excellence in research innovation and mentorship. Dr. Ravi Maharjan has demonstrated outstanding ability to secure funding, lead interdisciplinary projects, and foster scientific collaboration across countries and institutions, contributing to the advancement of mRNA and siRNA therapeutics, the optimization of excipients, and the improvement of drug delivery systems. His work on digital twins and AI/ML-driven process optimization has paved the way for predictive control in continuous manufacturing, ensuring reproducibility, efficiency, and quality in pharmaceutical production. In conclusion, Dr. Ravi Maharjan embodies the integration of scientific innovation, computational methods, and practical pharmaceutics expertise, making significant impacts in biopharmaceutical sciences, while continuing to mentor the next generation of researchers, drive technological innovation, and advance knowledge in AI-assisted pharmaceutical development.

Profile: Google Scholar

Featured Publications 

  1. Tripathi, J., Thapa, P., Maharjan, R., & Jeong, S. H. (2019). Current state and future perspectives on gastroretentive drug delivery systems. Citations: 246
  2. Maharjan, R., Hada, S., Lee, J. E., Han, H. K., Kim, K. H., Seo, H. J., Foged, C., … (2023). Comparative study of lipid nanoparticle-based mRNA vaccine bioprocess with machine learning and combinatorial artificial neural network-design of experiment approach. Citations: 48
  3. Maharjan, R., Kim, K. H., Lee, K., Han, H. K., & Jeong, S. H. (2024). Machine learning-driven optimization of mRNA-lipid nanoparticle vaccine quality with XGBoost/Bayesian method and ensemble model approaches. Citations: 44
  4. Maharjan, R., & Jeong, S. H. (2020). High shear seeded granulation: Its preparation mechanism, formulation, process, evaluation, and mathematical simulation. Citations: 37
  5. Bhujel, R., Maharjan, R., Kim, N. A., & Jeong, S. H. (2021). Practical quality attributes of polymeric microparticles with current understanding and future perspectives. Citations: 29
  6. Maharjan, R., Lee, J. C., Lee, K., Han, H. K., Kim, K. H., & Jeong, S. H. (2023). Recent trends and perspectives of artificial intelligence-based machine learning from discovery to manufacturing in biopharmaceutical industry. Citations: 28
  7. Kim, K. H., Lee, J. E., Lee, J. C., Maharjan, R., Oh, H., Lee, K., Kim, N. A., & Jeong, S. H. (2023). Optimization of HPLCCAD method for simultaneous analysis of different lipids in lipid nanoparticles with analytical QbD. Citations: 17

 

Ume Ruqia Tulain| Pharmaceutics | Best Researcher Award

Published on by Academic Achievements

Ume Ruqia Tulain| Pharmaceutics | Best Researcher Award

Dr. Ume Ruqia Tulain| Pharmaceutics |Assistant Professor at University of Sargodha , Pakistan

Dr. Ume Ruqia Tulain is an Assistant Professor at the Faculty of Pharmacy, University of Sargodha, Pakistan. With over 15 years of teaching and research experience, she specializes in pharmaceutics, focusing on controlled drug delivery systems. She holds a PhD in Pharmaceutics from The Islamia University of Bahawalpur. Dr. Tulain has published numerous papers in renowned international journals, and her research is recognized globally for its contributions to drug delivery technologies. She has actively participated in multiple national and international conferences, workshops, and seminars, contributing significantly to the pharmaceutical sciences community.

Professional Profile

Google Scholar

Scopus

Education

Dr. Ume Ruqia Tulain earned her B-Pharm, M.Phil, and PhD degrees from The Islamia University of Bahawalpur, Pakistan, completing her education with top distinctions. She completed her Matriculation and F.Sc from BISE Sargodha, achieving first divisions. Her academic journey reflects a strong foundation in pharmacy and a commitment to advancing the field of pharmaceutics.

Experience

Dr. Tulain has been an integral part of the Faculty of Pharmacy at the University of Sargodha since 2008, where she has held the roles of Lecturer and Assistant Professor. She has taught a wide array of subjects including Pharmaceutical Quality Management, Dosage Form Design, and Pharmaceutical Microbiology to both undergraduate and postgraduate students. Dr. Tulain also supervises M.Phil and PhD students and has served as an external examiner and reviewer for several international journals. She has been involved in various administrative committees at the university level as well.

Research Interests

Dr. Tulain’s research focuses on the development of controlled drug delivery systems using graft copolymers, hydrogels, microspheres, and nanoparticles as drug carriers. Her work is aimed at improving the efficacy and safety of pharmaceutical formulations. She has conducted significant research in oral controlled drug delivery and formulation development, with a special interest in the in vitro and in vivo evaluation of novel drug carriers.

Awards

Dr. Tulain has received multiple awards for her outstanding research contributions. In 2022 and 2023, she was honored with the “Research Award in recognition of outstanding research publication” for her prolific work in pharmaceutical sciences. Additionally, her research projects have garnered attention, including the successful co-investigation of a project on controlled drug delivery systems. She was also a recipient of the “Best Researcher” award at the University of Sargodha.

Publications

Nigella sativa (Prophetic Medicine): A Review

Citations: 131

Lactic acid bacteria in traditional fermented Asian foods

Citations: 78

Preparation and characterization of pH sensitive crosslinked Linseed polysaccharides-co-acrylic acid/methacrylic acid hydrogels for controlled delivery of ketoprofen

Citations: 51

Fabrication of Ph‐responsive hydrogel and its in vitro and in vivo evaluation

Citations: 50

β-cyclodextrin chitosan-based hydrogels with tunable pH-responsive properties for controlled release of acyclovir: design, characterization, safety, and pharmacokinetic evaluation

Citations: 42

Acute toxicity studies of a novel excipient arabinoxylan isolated from Ispaghula (Plantago ovata) husk

Citations: 39

Thiolation of arabinoxylan and its application in the fabrication of pH-sensitive thiolated arabinoxylan grafted acrylic acid copolymer

Citations: 35

Design and in vitro evaluation of pH-sensitive crosslinked chitosan-grafted acrylic acid copolymer (CS-co-AA) for targeted drug delivery

Citations: 33

pH sensitive pluronic acid/agarose-hydrogels as controlled drug delivery carriers: design, characterization and toxicity evaluation

Citations: 26

Microwave radiation induced synthesis of hydroxypropyl methylcellulose-graft-(polyvinylalcohal-co-acrylic acid) polymeric network and its in vitro evaluation

Citations: 24

 

Conclusion

Dr. Tulain’s exceptional research output, coupled with her commitment to advancing pharmaceutical sciences and fostering academic excellence, positions her as an outstanding candidate for the “Best Researcher Award.” Her consistent contributions, coupled with her leadership in the research community, make her an excellent role model and deserving of this recognition.